Portage Biotech Inc. is a listed company. Its insiders report their share dealings to SEDI. The past year has been quiet: not a single insider filing for Portage Biotech Inc. The previous disclosure was published on 12 March 2022.
Since 2016, the database holds 31 purchases and 12 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 110 declarations
Portage Biotech Inc. is a biotechnology company focused on developing treatments for cancer. It is listed on the XTSE market.